1. Home
  2. SXI vs RCUS Comparison

SXI vs RCUS Comparison

Compare SXI & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Standex International Corporation

SXI

Standex International Corporation

HOLD

Current Price

$270.23

Market Cap

3.2B

Sector

Industrials

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.39

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SXI
RCUS
Founded
1955
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
SXI
RCUS
Price
$270.23
$23.39
Analyst Decision
Strong Buy
Buy
Analyst Count
3
11
Target Price
$281.33
$30.27
AVG Volume (30 Days)
164.3K
844.5K
Earning Date
04-30-2026
05-05-2026
Dividend Yield
0.51%
N/A
EPS Growth
N/A
N/A
EPS
1.42
N/A
Revenue
$604,535,000.00
$247,000,000.00
Revenue This Year
$14.87
N/A
Revenue Next Year
$6.07
$83.23
P/E Ratio
$187.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$128.85
$7.06
52 Week High
$277.35
$26.40

Technical Indicators

Market Signals
Indicator
SXI
RCUS
Relative Strength Index (RSI) 58.66 56.38
Support Level $243.78 $20.18
Resistance Level $277.35 $24.33
Average True Range (ATR) 8.30 1.07
MACD 1.15 0.16
Stochastic Oscillator 79.38 85.79

Price Performance

Historical Comparison
SXI
RCUS

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: